Our Firm is representing clients who have filed testosterone claims in this proceeding, and we continue to receive inquiries from others who were allegedly harmed by testosterone replacement therapy.
New York, New York (PRWEB) April 17, 2015
Testosterone treatment lawsuits (http://www.testosteronelawsuithub.com/) that allege this class of prescription medications increases the likelihood that a man will suffer a heart attack, stroke or other life-threatening cardiovascular event continue to mount in a multidistrict litigation underway in U.S. District Court, Northern District of Illinois. According to an updated Statistics Report issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on April 15th, 1,382 cases are now pending in the proceeding. This indicates that 210 new testosterone lawsuits have been filed in the Northern District of Illinois since the Panel issued its previous report on March 16th, when 1,172 cases were noted. (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)
“Our Firm is representing clients who have filed testosterone claims in this proceeding, and we continue to receive inquiries from others who were allegedly harmed by testosterone replacement therapy. We do not find it surprising that new cases are being filed in this litigation every month,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm continues to offer free case reviews to men who allegedly experienced dangerous cardiovascular side effects due to low testosterone treatments.
According to court documents, millions of men have allegedly used testosterone replacement therapies to combat symptoms typically associated with ageing, even though the medications are only approved to treat hypogonadism, a condition in which levels of the hormone drop due to an underlying injury or illness. The federal testosterone litigation underway in Illinois was established by the JPML in June 2014, and initially included only about four dozen cases. The Panel’s June 6th Order noted that all of the actions had been filed in the wake of the U.S. Food & Drug Administration’s (FDA) January 31, 2014 announcement that it was reviewing the cardiovascular risks allegedly associated with testosterone therapy.* On March 3, 2015, the FDA updated its alert, and ordered the manufacturers of prescription testosterone treatments to add new information to their labels regarding the drugs’ potential to increase a patient’s risk for heart attacks and strokes. The alert also noted that the labels would be modified to make it clear that such therapy had not been shown safe and effective for relieving symptoms associated with age-related drops in testosterone.
Court records indicate that all of the testosterone lawsuits pending in the federal litigation were filed on behalf of men who allegedly experienced heart attacks, strokes, blood clots and other cardiovascular events due to their use of the medications. The claims accuse the drugs’ manufacturers of failing to adequately warn patients of these risks, and of wrongly marketing their testosterone therapies as appropriate treatments for low libido, muscle loss, fatigue and other symptoms commonly associated with male aging.
Men who allegedly suffered heart attacks, strokes, deep vein thrombosis, pulmonary embolism or other serious cardiovascular events due to their use of low testosterone therapy may be eligible for compensation for medical bills, lost wages and other injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.
*fda.gov/Drugs/DrugSafety/ucm383904.htm, FDA, January 31, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The National Law Journal has recognized Bernstein Liebhard for twelve consecutive years as one of the top plaintiffs' firms in the country. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com